Page last updated: 2024-11-12
bde 197
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
2,2',3,3',4,4',6,6'-octabromodiphenyl ether: a component of DE-79, a technical octabromo diphenyl ether mixture [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11967214 |
| SCHEMBL ID | 16678495 |
| MeSH ID | M0499999 |
Synonyms (16)
| Synonym |
|---|
| 1,2,3,5-tetrabromo-4-(2,3,4,6-tetrabromophenoxy)benzene |
| 117964-21-3 |
| bde-197 |
| unii-1sd9vs79j1 |
| bde197 |
| 1sd9vs79j1 , |
| bde 197 |
| 2,2',3,3',4,4',6,6'-octabromodiphenyl ether |
| benzene, 1,1'-oxybis(2,3,4,6-tetrabromo- |
| pbde 197 |
| AAFUUKPTSPVXJH-UHFFFAOYSA-N |
| DTXSID9074775 |
| SCHEMBL16678495 |
| Q27252833 |
| 2,2 3,3,4,4 6,6-octabromodiphenyl ether |
| benzene, 1,2,3,5-tetrabromo-4-(2,3,4,6-tetrabromophenoxy)- |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| " However, compared with single chemical exposure, the larval offspring at 5 dpf from the coexposure groups had reversed the adverse influences from maternal origin." | ( Transgenerational endocrine disruption and neurotoxicity in zebrafish larvae after parental exposure to binary mixtures of decabromodiphenyl ether (BDE-209) and lead. Chen, L; Guo, Y; Lam, JCW; Lam, PKS; Wang, X; Zhang, X; Zhou, B, 2017) | 0.46 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||